1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Willbold, D.
Hoffmann, S.
Rosch, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
245
581
588
10.1111/j.1432-1033.1997.t01-1-00581.x
9182993
Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution.
1997
10.2210/pdb1vpu/pdb
pdb_00001vpu
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5111.440
VPU PROTEIN
CYTOPLASMIC DOMAIN RESIDUES 39 - 81
R37L, K38Q
1
man
polymer
VPU(39-81)
no
no
LQIDRLIDRITERAEDSGNESEGDQEELSALVERGHLAPWDVDDL
LQIDRLIDRITERAEDSGNESEGDQEELSALVERGHLAPWDVDDL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lentivirus
SF162 ISOLATE
Escherichia
Escherichia coli
sample
BL21
SYNTHETIC GENE
11676
Human immunodeficiency virus 1
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PET16B (NOVAGEN)
PLASMID
PET16B (NOVAGEN)
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-05-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-01-28
REL
REL
REPRESENTATIVE MODEL NUMBER: 3
ENERGY, AGREEMENT WITH EXPERIMENTAL DATA
25
9
NOESY (100
150
200 MS MIXING TIME)
7.0
298
K
SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS
structure solution
NDEE
structure solution
X-PLOR
refinement
X-PLOR
600
Bruker
AMX600
LEU
37
n
1
LEU
37
A
GLN
38
n
2
GLN
38
A
ILE
39
n
3
ILE
39
A
ASP
40
n
4
ASP
40
A
ARG
41
n
5
ARG
41
A
LEU
42
n
6
LEU
42
A
ILE
43
n
7
ILE
43
A
ASP
44
n
8
ASP
44
A
ARG
45
n
9
ARG
45
A
ILE
46
n
10
ILE
46
A
THR
47
n
11
THR
47
A
GLU
48
n
12
GLU
48
A
ARG
49
n
13
ARG
49
A
ALA
50
n
14
ALA
50
A
GLU
51
n
15
GLU
51
A
ASP
52
n
16
ASP
52
A
SER
53
n
17
SER
53
A
GLY
54
n
18
GLY
54
A
ASN
55
n
19
ASN
55
A
GLU
56
n
20
GLU
56
A
SER
57
n
21
SER
57
A
GLU
58
n
22
GLU
58
A
GLY
59
n
23
GLY
59
A
ASP
60
n
24
ASP
60
A
GLN
61
n
25
GLN
61
A
GLU
62
n
26
GLU
62
A
GLU
63
n
27
GLU
63
A
LEU
64
n
28
LEU
64
A
SER
65
n
29
SER
65
A
ALA
66
n
30
ALA
66
A
LEU
67
n
31
LEU
67
A
VAL
68
n
32
VAL
68
A
GLU
69
n
33
GLU
69
A
ARG
70
n
34
ARG
70
A
GLY
71
n
35
GLY
71
A
HIS
72
n
36
HIS
72
A
LEU
73
n
37
LEU
73
A
ALA
74
n
38
ALA
74
A
PRO
75
n
39
PRO
75
A
TRP
76
n
40
TRP
76
A
ASP
77
n
41
ASP
77
A
VAL
78
n
42
VAL
78
A
ASP
79
n
43
ASP
79
A
ASP
80
n
44
ASP
80
A
LEU
81
n
45
LEU
81
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
41
0.317
SIDE CHAIN
1
A
ARG
45
0.291
SIDE CHAIN
1
A
ARG
49
0.283
SIDE CHAIN
1
A
ARG
70
0.290
SIDE CHAIN
2
A
ARG
41
0.306
SIDE CHAIN
2
A
ARG
45
0.280
SIDE CHAIN
2
A
ARG
49
0.315
SIDE CHAIN
2
A
ARG
70
0.282
SIDE CHAIN
3
A
ARG
41
0.304
SIDE CHAIN
3
A
ARG
45
0.317
SIDE CHAIN
3
A
ARG
49
0.296
SIDE CHAIN
3
A
ARG
70
0.318
SIDE CHAIN
4
A
ARG
45
0.303
SIDE CHAIN
4
A
ARG
49
0.251
SIDE CHAIN
4
A
ARG
70
0.297
SIDE CHAIN
5
A
ARG
41
0.281
SIDE CHAIN
5
A
ARG
45
0.269
SIDE CHAIN
5
A
ARG
49
0.287
SIDE CHAIN
5
A
ARG
70
0.303
SIDE CHAIN
6
A
ARG
41
0.258
SIDE CHAIN
6
A
ARG
45
0.310
SIDE CHAIN
6
A
ARG
49
0.319
SIDE CHAIN
6
A
ARG
70
0.303
SIDE CHAIN
7
A
ARG
41
0.269
SIDE CHAIN
7
A
ARG
45
0.199
SIDE CHAIN
7
A
ARG
49
0.261
SIDE CHAIN
7
A
ARG
70
0.292
SIDE CHAIN
8
A
ARG
41
0.306
SIDE CHAIN
8
A
ARG
45
0.310
SIDE CHAIN
8
A
ARG
49
0.288
SIDE CHAIN
8
A
ARG
70
0.290
SIDE CHAIN
9
A
ARG
41
0.307
SIDE CHAIN
9
A
ARG
45
0.289
SIDE CHAIN
9
A
ARG
49
0.258
SIDE CHAIN
9
A
ARG
70
0.215
SIDE CHAIN
1
A
ILE
39
-64.25
-77.64
1
A
GLU
51
56.64
6.65
1
A
GLU
56
-69.49
98.13
1
A
SER
57
78.10
-11.62
1
A
GLU
58
37.06
-129.00
1
A
LEU
64
-96.63
-85.58
1
A
SER
65
59.91
160.81
1
A
ALA
66
65.00
-64.32
1
A
ARG
70
-46.00
104.76
1
A
LEU
73
-51.01
105.96
1
A
ALA
74
-172.08
-170.94
2
A
ASP
40
74.97
-25.73
2
A
GLU
51
61.79
-30.87
2
A
SER
53
-93.07
33.67
2
A
GLU
58
71.51
-62.68
2
A
SER
65
60.00
-90.96
2
A
GLU
69
-84.12
42.75
2
A
HIS
72
177.48
-46.23
2
A
LEU
73
20.56
90.71
2
A
ALA
74
-176.38
-165.67
3
A
GLU
51
54.18
14.59
3
A
SER
57
-164.52
47.83
3
A
LEU
67
-107.52
-60.14
3
A
VAL
68
47.90
72.14
3
A
ARG
70
-67.10
79.91
3
A
HIS
72
41.51
94.32
3
A
ALA
74
-170.56
-170.63
4
A
GLN
38
-172.49
84.11
4
A
ILE
39
-81.20
-109.90
4
A
GLU
51
54.81
13.49
4
A
GLU
58
50.98
-109.83
4
A
GLU
69
-59.91
-9.14
4
A
ARG
70
-43.88
108.59
4
A
ALA
74
-171.77
-171.34
5
A
GLN
38
-141.78
58.58
5
A
GLU
51
57.32
-43.86
5
A
SER
53
-98.99
39.10
5
A
GLU
58
57.35
75.52
5
A
LEU
64
-174.81
-42.04
5
A
SER
65
-21.27
-44.98
5
A
ALA
66
-16.02
-66.60
5
A
LEU
67
-99.25
-79.87
5
A
ALA
74
-160.55
-160.04
5
A
PRO
75
-62.77
-93.70
5
A
TRP
76
26.32
-80.64
6
A
GLU
51
56.72
10.05
6
A
SER
57
72.85
-62.89
6
A
GLU
58
75.25
124.19
6
A
SER
65
64.97
-58.42
6
A
VAL
68
-91.56
58.85
6
A
HIS
72
-151.74
-42.11
7
A
GLN
38
61.88
63.40
7
A
ILE
39
-122.16
-66.09
7
A
SER
57
70.95
-65.12
7
A
GLU
58
73.18
128.94
7
A
SER
65
-26.87
-42.97
7
A
LEU
67
-105.44
-60.48
7
A
VAL
68
51.97
72.67
7
A
HIS
72
28.23
58.66
7
A
LEU
73
-66.65
-157.73
7
A
ALA
74
65.91
-171.45
8
A
ASP
40
73.35
-46.50
8
A
GLU
51
53.76
19.96
8
A
SER
57
68.41
-61.67
8
A
GLU
58
76.41
115.13
8
A
GLU
62
-143.66
-50.96
8
A
LEU
64
-67.10
-71.82
8
A
SER
65
53.71
-157.71
8
A
ALA
66
65.12
-62.77
8
A
ASP
80
74.41
-61.66
9
A
ILE
39
-108.85
-111.62
9
A
GLU
51
59.69
-42.35
9
A
SER
57
-101.05
-61.69
9
A
GLU
58
147.89
53.28
9
A
LEU
64
-105.32
-60.66
9
A
SER
65
68.42
-52.59
9
A
ALA
66
-45.14
-72.31
9
A
LEU
67
-66.44
-79.01
9
A
VAL
68
30.50
61.97
9
A
GLU
69
-69.35
33.02
9
A
HIS
72
-155.52
-64.68
9
A
LEU
73
162.15
-179.85
9
A
ALA
74
53.16
-169.07
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
NMR SOLUTION STRUCTURE OF THE HIV-1 VPU CYTOPLASMIC DOMAIN, 9 STRUCTURES
1
Y
N
A
ASP
40
A
ASP
4
HELX_P
A
ALA
50
A
ALA
14
1
1
11
A
ASP
60
A
ASP
24
HELX_P
A
GLU
63
A
GLU
27
5
2
4
A
PRO
75
A
PRO
39
HELX_P
A
VAL
78
A
VAL
42
1
3
4
AIDS
HIV, VPU, AIDS
VPU_HV1S1
UNP
1
1
P19554
MQPLQILAIVALVVAAIIAIVVWTIVYIEYRKILRQRKIDRLIDRITERAEDSGNESEGDQEELSALVERGHLAPWDVDD
L
39
81
1VPU
39
81
P19554
A
1
3
45
1
P 1